- Home
- AMBP vs WGS Comparison
AMBP vs WGS Comparison
Compare AMBP & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBP
- WGS
- Stock Information
- Founded
- AMBP 2021
- WGS 2017
- Country
- AMBP Luxembourg
- WGS United States
- Employees
- AMBP N/A
- WGS N/A
- Industry
- AMBP Containers/Packaging
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- AMBP Industrials
- WGS Technology
- Exchange
- AMBP Nasdaq
- WGS Nasdaq
- Market Cap
- AMBP 1.9B
- WGS 2.0B
- IPO Year
- AMBP N/A
- WGS N/A
- Fundamental
- Price
- AMBP $3.01
- WGS $92.20
- Analyst Decision
- AMBP Hold
- WGS Strong Buy
- Analyst Count
- AMBP 5
- WGS 5
- Target Price
- AMBP $3.34
- WGS $82.60
- AVG Volume (30 Days)
- AMBP 1.6M
- WGS 707.5K
- Earning Date
- AMBP 04-24-2025
- WGS 04-28-2025
- Dividend Yield
- AMBP 13.33%
- WGS N/A
- EPS Growth
- AMBP N/A
- WGS N/A
- EPS
- AMBP N/A
- WGS N/A
- Revenue
- AMBP $4,908,000,000.00
- WGS $305,450,000.00
- Revenue This Year
- AMBP $4.05
- WGS $18.58
- Revenue Next Year
- AMBP $2.64
- WGS $17.65
- P/E Ratio
- AMBP N/A
- WGS N/A
- Revenue Growth
- AMBP 2.00
- WGS 50.79
- 52 Week Low
- AMBP $2.50
- WGS $8.53
- 52 Week High
- AMBP $4.26
- WGS $115.60
- Technical
- Relative Strength Index (RSI)
- AMBP 58.98
- WGS 48.23
- Support Level
- AMBP $2.84
- WGS $93.40
- Resistance Level
- AMBP $3.03
- WGS $107.98
- Average True Range (ATR)
- AMBP 0.10
- WGS 6.97
- MACD
- AMBP 0.01
- WGS -0.87
- Stochastic Oscillator
- AMBP 96.10
- WGS 27.49
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.